(Q47376557)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22804715%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

One-year effect of a supervised exercise programme on functional capacity and quality of life in peripheral arterial disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22804715%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22804715%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Marie Guidon

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22804715%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

18 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22804715%20AND%20SRC:MED&resulttype=core&format=json

Disability and Rehabilitation

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22804715%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22804715%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

397-404

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22804715%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22804715%20AND%20SRC:MED&resulttype=core&format=json

Mortality over a period of 10 years in patients with peripheral arterial disease

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Physical activity during daily life and functional decline in peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Physical activity during daily life and mortality in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Physical activity is a predictor of all-cause mortality in patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Peripheral artery disease: current insight into the disease and its diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Medical treatment of peripheral arterial disease and claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Exercise training versus angioplasty for stable claudication. Long and medium term results of a prospective, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascul

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Early outcomes from a randomized, controlled trial of supervised exercise, angioplasty, and combined therapy in intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Association between daily ambulatory activity patterns and exercise performance in patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Does supervised exercise offer adjuvant benefit over exercise advice alone for the treatment of intermittent claudication? A randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society f

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Coun

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Rehabilitation in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

A systematic review of randomized controlled trials: Walking versus alternative exercise prescription as treatment for intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Upper- versus lower-limb aerobic exercise training on health-related quality of life in patients with symptomatic peripheral arterial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Exercise rehabilitation for the patient with intermittent claudication: a highly effective yet underutilized treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Quality of life and objective disease criteria in patients with intermittent claudication in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Quality of life and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Exercise training for claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Gait alterations associated with walking impairment in people with peripheral arterial disease with and without intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Intermittent claudication: functional capacity and quality of life after exercise training or percutaneous transluminal angioplasty--systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963

Maintenance of exercise capacity and physical activity patterns 2 years after cardiac rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09638288.2012.694963